Zhengye Biotechnology
(NASDAQ) ZYBT
Zhengye Biotechnology Financials at a Glance
Market Cap
$41.67M
Revenue (TTM)
N/A
Net Income (TTM)
N/A
EPS (TTM)
$-0.06
P/E Ratio
-15.62
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$0.86
Volume
96
Open
$0.86
Price
$0.86
Volume
96
Open
$0.86
Previous Close
$0.86
Daily Range
$0.86 - $0.86
52-Week Range
$0.68 - $14.30
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$0.86
Volume
96
Open
$0.86
Previous Close
$0.86
Daily Range
$0.86 - $0.86
52-Week Range
$0.68 - $14.30
ZYBT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zhengye Biotechnology
Industry
Pharmaceuticals
Sector
Health CareEmployees
277
CEO
Song Lin Song
Website
www.jlzybio.comHeadquarters
Jilin, 132101, CN
ZYBT Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
9%
Net Income Margin
6%
Return on Equity
-7%
Return on Capital
5%
Return on Assets
2%
Earnings Yield
-6.40%
Dividend Yield
0.00%
Payout Ratio
1.42%
Stock Overview
Market Cap
$41.67M
Shares Outstanding
47.39M
Volume
96
Short Interest
0.00%
Avg. Volume
210.85K
Financials (TTM)
Gross Profit
$91.30M
Operating Income
$16.44M
EBITDA
$42.60M
Operating Cash Flow
$41.05M
Capital Expenditure
$27.77M
Free Cash Flow
$13.27M
Cash & ST Invst.
$20.04M
Total Debt
$86.43M
Zhengye Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
N/A
N/A
Gross Profit
N/A
N/A
Gross Margin
N/A
N/A
Market Cap
$41.67M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
N/A
N/A
EBITDA
N/A
N/A
Quarterly Fundamentals
Net Cash
N/A
N/A
Accounts Receivable
N/A
N/A
Inventory
N/A
N/A
Long Term Debt
N/A
N/A
Short Term Debt
N/A
N/A
Return on Assets
N/A
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
N/A
N/A
Operating Cash Flow
N/A
N/A